Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Xenon Pharmaceuticals Inc (XENE)

Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Xenon to Present at Upcoming Investor Conferences GlobeNewswire - Wed Nov 13, 3:01PM CST

XENE : 40.39 (+2.67%)
Xenon Pharmaceuticals: Q3 Earnings Snapshot AP - Tue Nov 12, 3:07PM CST

Xenon Pharmaceuticals: Q3 Earnings Snapshot

XENE : 40.39 (+2.67%)
Xenon Reports Q3 2024 Financial Results and Business Update GlobeNewswire - Tue Nov 12, 3:01PM CST

XENE : 40.39 (+2.67%)
Xenon to Report Q3 2024 Financial Results on November 12, 2024 GlobeNewswire - Tue Nov 5, 3:01PM CST

XENE : 40.39 (+2.67%)
Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe
Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe Zacks Investment Research - Fri Oct 11, 10:30AM CDT

Intra-Cellular ITCI is focused on discovering, developing and commercializing small molecule drugs for treating neuropsychiatric and neurological disorders. The company currently has only one marketed...

ITCI : 85.37 (-0.32%)
XENE : 40.39 (+2.67%)
AXSM : 97.32 (+2.88%)
Xenon Pharmaceuticals: Q2 Earnings Snapshot AP - Thu Aug 8, 3:26PM CDT

Xenon Pharmaceuticals: Q2 Earnings Snapshot

XENE : 40.39 (+2.67%)
Xenon Pharmaceuticals: Q1 Earnings Snapshot AP - Thu May 9, 3:17PM CDT

Xenon Pharmaceuticals: Q1 Earnings Snapshot

XENE : 40.39 (+2.67%)
Xenon Pharmaceuticals: Q4 Earnings Snapshot AP - Thu Feb 29, 3:13PM CST

Xenon Pharmaceuticals: Q4 Earnings Snapshot

XENE : 40.39 (+2.67%)
Cerence, Roivant Sciences fall; Xenon Pharmaceuticals, Shopify rise, Monday, 11/27/2023 Associated Press - Mon Nov 27, 2023

Stocks that traded heavily or had substantial price changes on Monday: Cerence, Roivant Sciences fall; Xenon Pharmaceuticals, Shopify rise

CRNC : 6.13 (+117.38%)
SHOP.TO : 149.50 (+2.86%)
NEM : 43.09 (+0.23%)
XENE : 40.39 (+2.67%)
FCX : 43.91 (+0.48%)
Xenon Pharmaceuticals: Q3 Earnings Snapshot AP - Wed Nov 8, 2023

Xenon Pharmaceuticals: Q3 Earnings Snapshot

XENE : 40.39 (+2.67%)

Barchart Exclusives

ELF’s Unusual Options Activity Is a Thing of Questionable Beauty Barchart - 22 minutes ago
E.L.F. Beauty’s options volume on Wednesday was 7x the 30-day average. The affordable makeup and skincare company’s unusual options activity stood out as one investor questioned its revenues. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot